Novo Nordisk opens three Diabetes clinics
Novo Nordisk has opened three Diabetes Clinics which was part of the
grant of Rs. 25 million to repair, rebuild and upgrade the diabetes care
General Hospital of Kandy, Teaching Hospital of Peradeniya and
General Hospital of Badulla were the recipients of this grant by Novo
Five clinics have been opened by Novo Nordisk, with the first two at
the Karapitiya General Hospital and National Hospital of Sri Lanka,
The company said "we would not be able to protect ourselves against
another 'tsunami' of preventable non communicable diseases such as
diabetes which is looming large on the horizon.
We need to take action now to protect the millions from developing
diabetes to prevent yet another disaster. Hopefully these clinics will
play a small but significant role to achieve that objective."
This was made known at a ceremony to mark the opening of the Diabetes
clinics in Badulla, Peradeniya and Kandy.
Minister of Healthcare, Nutrition and Uva Wellasa Development, Nimal
Siripala de Silva, thanked Novo Nordisk for the contribution and said
"With improving health services provided by the state, the health status
of the people has improved resulting in an increased life expectancy.
Since people's literacy rate is high, in Sri Lanka, the public is
aware about diseases such as diabetes and its complications affecting
all vital organs in the body. Early detection and continuous monitoring
of diabetes can help a patient to be free of its complications affecting
all vital organs in the body.
Early detection and continuous monitoring of diabetes can help a
patient to be free of its complications."
Country Manager Sri Lanka Novo Nordisk Paul Amirtharaj said, "Soon
after the tsunami we were very happy that our CEO announced a donation
of 1.5 million DKK (Rs. 25 million) as Novo Nordisk's contribution to
help Sri Lanka rebuild and upgrade its healthcare infrastructure.
In consultation with the Ministry of Health it was decided to use the
fund to set up Seven Diabetes Care Clinics within the existing public
healthcare system. We are very pleased to have completed five of these
clinics and look forward to opening the next two shortly."
Dr. H.A.P. Kahandaliyanage, Director General of Health Services and
G. Sathasivam, Chairman, Swiss Biogenics Ltd., Novo Nordisk's local
partner, and Vish Govindasamy, Managing Director, presided over the